US Stock MarketDetailed Quotes

JNJ Johnson & Johnson

Watchlist
  • 145.050
  • -0.530-0.36%
Close Dec 27 16:00 ET
  • 145.160
  • +0.110+0.08%
Post 20:01 ET
349.23BMarket Cap23.59P/E (TTM)

Johnson & Johnson Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 29, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Oct 1, 2023
(Q2)Jun 30, 2023
(Q1)Apr 2, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
5.25%22.47B
4.31%22.45B
2.34%21.38B
6.46%85.16B
7.30%21.4B
6.78%21.35B
-10.41%21.52B
-10.81%20.89B
1.59%79.99B
104.10%19.94B
Operating revenue
5.25%22.47B
4.31%22.45B
2.34%21.38B
6.46%85.16B
7.30%21.4B
6.78%21.35B
-10.41%21.52B
-10.81%20.89B
1.59%79.99B
104.10%19.94B
Cost of revenue
5.40%6.96B
6.30%6.87B
-2.63%6.51B
7.96%26.55B
11.74%6.8B
7.03%6.61B
-18.40%6.46B
-11.99%6.69B
5.10%24.6B
305.06%6.08B
Gross profit
5.17%15.51B
3.46%15.58B
4.68%14.87B
5.80%58.61B
5.36%14.6B
6.66%14.75B
-6.48%15.06B
-10.24%14.21B
0.10%55.39B
67.59%13.86B
Operating expense
19.69%10.23B
2.55%8.92B
8.01%8.6B
6.08%35.2B
14.18%9.99B
4.74%8.55B
-9.66%8.7B
-18.01%7.96B
-3.53%33.18B
18.29%8.75B
Selling and administrative expenses
3.49%5.28B
9.71%5.48B
12.23%5.06B
5.60%20.11B
9.35%5.51B
9.09%5.1B
-15.69%5B
-20.08%4.51B
-5.33%19.05B
61.87%5.04B
-General and administrative expense
3.49%5.28B
9.71%5.48B
12.23%5.06B
5.60%20.11B
9.35%5.51B
9.09%5.1B
-15.69%5B
-20.08%4.51B
-5.33%19.05B
61.87%5.04B
Research and development costs
43.66%4.95B
-7.10%3.44B
2.52%3.54B
6.72%15.09B
20.75%4.48B
-1.09%3.45B
0.00%3.7B
-15.15%3.46B
-0.99%14.14B
-13.38%3.71B
Operating profit
-14.84%5.28B
4.70%6.66B
0.43%6.27B
5.38%23.41B
-9.77%4.61B
9.43%6.2B
-1.76%6.36B
2.09%6.25B
6.06%22.21B
486.22%5.11B
Net non-operating interest income expense
-45.60%99M
14.68%125M
1,592.86%209M
128.50%489M
175.32%212M
83.84%182M
319.23%109M
-216.67%-14M
264.62%214M
263.83%77M
Non-operating interest income
-21.93%292M
21.17%395M
83.84%364M
157.35%1.26B
42.91%363M
149.33%374M
409.38%326M
800.00%198M
824.53%490M
1,853.85%254M
Non-operating interest expense
0.52%193M
24.42%270M
-26.89%155M
179.71%772M
-14.69%151M
276.47%192M
471.05%217M
2,020.00%212M
50.82%276M
195.00%177M
Other net income (expense)
-75.34%-2.04B
-645.52%-1.08B
63.04%-2.76B
-187.84%-8.8B
99.70%-4M
-106.02%-1.16B
78.83%-145M
-2,670.00%-7.48B
-87.03%-3.06B
-410.60%-1.35B
Gain on sale of security
----
---400M
----
14.29%-600M
--500M
-400.00%-1B
----
75.00%-100M
---700M
--0
Special income (charges)
-862.50%-2.54B
-341.22%-1.08B
59.28%-2.96B
-193.98%-8.4B
51.60%-604M
43.23%-264M
68.79%-245M
-4,181.76%-7.28B
-157.71%-2.86B
-180.00%-1.25B
-Less：Restructuring and merger&acquisition
-10.76%141M
166.90%387M
103.08%264M
66.11%789M
25.82%346M
143.08%158M
70.59%145M
85.71%130M
127.27%475M
-49.07%275M
-Less:Impairment of capital assets
----
----
--0
----
----
----
----
--49M
----
----
-Less:Other special charges
2,500.00%2.4B
400.00%500M
-61.97%2.7B
219.47%7.61B
-47.28%513M
-125.00%-100M
-85.71%100M
7,000.00%7.1B
164.78%2.38B
146.33%973M
-Write off
--0
--194M
----
----
----
--206M
--0
----
----
----
Other non- operating income (expenses)
400.00%500M
300.00%400M
300.00%200M
-60.00%200M
200.00%100M
0.00%100M
-50.00%100M
-133.33%-100M
195.06%500M
87.89%-100M
Income before tax
-36.02%3.34B
-8.85%5.75B
388.58%3.71B
-22.20%15.06B
25.68%4.83B
0.87%5.22B
7.98%6.31B
-121.95%-1.29B
0.94%19.36B
210.18%3.84B
Income tax
-29.07%644M
14.19%1.06B
157.66%459M
-41.92%1.74B
13.21%694M
5.34%908M
-9.36%930M
-211.64%-796M
117.07%2.99B
245.61%613M
Net income
-89.65%2.69B
-8.90%4.69B
4,886.76%3.26B
95.94%35.15B
15.03%4.05B
483.85%26.03B
6.86%5.14B
-101.32%-68M
-14.07%17.94B
-25.68%3.52B
Net income continuous Operations
-37.48%2.69B
-12.83%4.69B
762.93%3.26B
-18.59%13.33B
28.04%4.13B
-0.02%4.31B
11.67%5.38B
-109.54%-491M
-8.04%16.37B
94.51%3.23B
Net income discontinuous operations
--0
--0
--0
1,289.37%21.83B
-128.33%-83M
14,575.00%21.72B
---232M
--423M
-48.94%1.57B
--293M
Minority interest income
Net income attributable to the parent company
-89.65%2.69B
-8.90%4.69B
4,886.76%3.26B
95.94%35.15B
15.03%4.05B
483.85%26.03B
6.86%5.14B
-101.32%-68M
-14.07%17.94B
-25.68%3.52B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-89.65%2.69B
-8.90%4.69B
4,886.76%3.26B
95.94%35.15B
15.03%4.05B
483.85%26.03B
6.86%5.14B
-101.32%-68M
-14.07%17.94B
-25.68%3.52B
Basic earnings per share
-89.15%1.12
-1.52%1.95
4,600.00%1.35
103.22%13.88
24.93%1.682
507.06%10.32
8.20%1.98
-101.53%-0.03
-13.87%6.83
-25.16%1.3463
Diluted earnings per share
-89.13%1.11
-1.53%1.93
4,566.67%1.34
103.86%13.72
25.56%1.67
507.74%10.21
8.89%1.96
-101.55%-0.03
-13.83%6.73
-24.86%1.33
Dividend per share
4.20%1.24
4.20%1.24
5.31%1.19
5.62%4.7
5.31%1.19
5.31%1.19
5.31%1.19
6.60%1.13
6.21%4.45
6.60%1.13
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 29, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Oct 1, 2023(Q2)Jun 30, 2023(Q1)Apr 2, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 5.25%22.47B4.31%22.45B2.34%21.38B6.46%85.16B7.30%21.4B6.78%21.35B-10.41%21.52B-10.81%20.89B1.59%79.99B104.10%19.94B
Operating revenue 5.25%22.47B4.31%22.45B2.34%21.38B6.46%85.16B7.30%21.4B6.78%21.35B-10.41%21.52B-10.81%20.89B1.59%79.99B104.10%19.94B
Cost of revenue 5.40%6.96B6.30%6.87B-2.63%6.51B7.96%26.55B11.74%6.8B7.03%6.61B-18.40%6.46B-11.99%6.69B5.10%24.6B305.06%6.08B
Gross profit 5.17%15.51B3.46%15.58B4.68%14.87B5.80%58.61B5.36%14.6B6.66%14.75B-6.48%15.06B-10.24%14.21B0.10%55.39B67.59%13.86B
Operating expense 19.69%10.23B2.55%8.92B8.01%8.6B6.08%35.2B14.18%9.99B4.74%8.55B-9.66%8.7B-18.01%7.96B-3.53%33.18B18.29%8.75B
Selling and administrative expenses 3.49%5.28B9.71%5.48B12.23%5.06B5.60%20.11B9.35%5.51B9.09%5.1B-15.69%5B-20.08%4.51B-5.33%19.05B61.87%5.04B
-General and administrative expense 3.49%5.28B9.71%5.48B12.23%5.06B5.60%20.11B9.35%5.51B9.09%5.1B-15.69%5B-20.08%4.51B-5.33%19.05B61.87%5.04B
Research and development costs 43.66%4.95B-7.10%3.44B2.52%3.54B6.72%15.09B20.75%4.48B-1.09%3.45B0.00%3.7B-15.15%3.46B-0.99%14.14B-13.38%3.71B
Operating profit -14.84%5.28B4.70%6.66B0.43%6.27B5.38%23.41B-9.77%4.61B9.43%6.2B-1.76%6.36B2.09%6.25B6.06%22.21B486.22%5.11B
Net non-operating interest income expense -45.60%99M14.68%125M1,592.86%209M128.50%489M175.32%212M83.84%182M319.23%109M-216.67%-14M264.62%214M263.83%77M
Non-operating interest income -21.93%292M21.17%395M83.84%364M157.35%1.26B42.91%363M149.33%374M409.38%326M800.00%198M824.53%490M1,853.85%254M
Non-operating interest expense 0.52%193M24.42%270M-26.89%155M179.71%772M-14.69%151M276.47%192M471.05%217M2,020.00%212M50.82%276M195.00%177M
Other net income (expense) -75.34%-2.04B-645.52%-1.08B63.04%-2.76B-187.84%-8.8B99.70%-4M-106.02%-1.16B78.83%-145M-2,670.00%-7.48B-87.03%-3.06B-410.60%-1.35B
Gain on sale of security -------400M----14.29%-600M--500M-400.00%-1B----75.00%-100M---700M--0
Special income (charges) -862.50%-2.54B-341.22%-1.08B59.28%-2.96B-193.98%-8.4B51.60%-604M43.23%-264M68.79%-245M-4,181.76%-7.28B-157.71%-2.86B-180.00%-1.25B
-Less：Restructuring and merger&acquisition -10.76%141M166.90%387M103.08%264M66.11%789M25.82%346M143.08%158M70.59%145M85.71%130M127.27%475M-49.07%275M
-Less:Impairment of capital assets ----------0------------------49M--------
-Less:Other special charges 2,500.00%2.4B400.00%500M-61.97%2.7B219.47%7.61B-47.28%513M-125.00%-100M-85.71%100M7,000.00%7.1B164.78%2.38B146.33%973M
-Write off --0--194M--------------206M--0------------
Other non- operating income (expenses) 400.00%500M300.00%400M300.00%200M-60.00%200M200.00%100M0.00%100M-50.00%100M-133.33%-100M195.06%500M87.89%-100M
Income before tax -36.02%3.34B-8.85%5.75B388.58%3.71B-22.20%15.06B25.68%4.83B0.87%5.22B7.98%6.31B-121.95%-1.29B0.94%19.36B210.18%3.84B
Income tax -29.07%644M14.19%1.06B157.66%459M-41.92%1.74B13.21%694M5.34%908M-9.36%930M-211.64%-796M117.07%2.99B245.61%613M
Net income -89.65%2.69B-8.90%4.69B4,886.76%3.26B95.94%35.15B15.03%4.05B483.85%26.03B6.86%5.14B-101.32%-68M-14.07%17.94B-25.68%3.52B
Net income continuous Operations -37.48%2.69B-12.83%4.69B762.93%3.26B-18.59%13.33B28.04%4.13B-0.02%4.31B11.67%5.38B-109.54%-491M-8.04%16.37B94.51%3.23B
Net income discontinuous operations --0--0--01,289.37%21.83B-128.33%-83M14,575.00%21.72B---232M--423M-48.94%1.57B--293M
Minority interest income
Net income attributable to the parent company -89.65%2.69B-8.90%4.69B4,886.76%3.26B95.94%35.15B15.03%4.05B483.85%26.03B6.86%5.14B-101.32%-68M-14.07%17.94B-25.68%3.52B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -89.65%2.69B-8.90%4.69B4,886.76%3.26B95.94%35.15B15.03%4.05B483.85%26.03B6.86%5.14B-101.32%-68M-14.07%17.94B-25.68%3.52B
Basic earnings per share -89.15%1.12-1.52%1.954,600.00%1.35103.22%13.8824.93%1.682507.06%10.328.20%1.98-101.53%-0.03-13.87%6.83-25.16%1.3463
Diluted earnings per share -89.13%1.11-1.53%1.934,566.67%1.34103.86%13.7225.56%1.67507.74%10.218.89%1.96-101.55%-0.03-13.83%6.73-24.86%1.33
Dividend per share 4.20%1.244.20%1.245.31%1.195.62%4.75.31%1.195.31%1.195.31%1.196.60%1.136.21%4.456.60%1.13
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Ecopetrol
EC
0.00%
Petroleo Brasileiro SA Petrobras
PBR
-0.13%
Vale SA
VALE
-0.45%
Meta Platforms
META
-0.59%
Adobe
ADBE
-0.82%

Unlock the Full List

Investment Theme Infectious Disease
Infectious Disease
Intraday-0.10%
CAR-T Therapy
CAR-T Therapy
Intraday-0.17%